You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Storage

Showing 26 - 50 of 4,265
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetes Type 2 Trial in Sherbrooke (Bariatric surgery, Nicotinic Acid)

Not yet recruiting
  • Diabetes Mellitus Type 2
  • Bariatric surgery
  • Nicotinic Acid
  • Sherbrooke, Quebec, Canada
    centre de recherche du CHUS
Jun 27, 2023

Anxiety Trial (Lethal Means Counseling (LMC), CBT for Uncertainty - Enhanced (CUE))

Not yet recruiting
  • Anxiety
  • Lethal Means Counseling (LMC)
  • CBT for Uncertainty - Enhanced (CUE)
  • (no location specified)
Apr 19, 2023

Mental Health Disorders, Suicide or Selfinflicted Injury by Firearms and Explosives Trial in Seattle (Free safe firearm storage

Completed
  • Mental Health Disorders
  • Suicide or Selfinflicted Injury by Firearms and Explosives
  • Free safe firearm storage device distribution
  • Low cost safe firearm storage device
  • Seattle, Washington
    Seattle Children's
May 3, 2022

Inborn Errors of Cholesterol Synthesis and Related Disorders

Recruiting
  • Lysosomal Storage Disease
  • Cholesterol Metabolism
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Dec 28, 2022

    Glycogen Storage Disease Type II Infantile Onset Trial in Gainesville (Cipaglucosidase alfa (ATB200), Miglustat (AT2221))

    Recruiting
    • Glycogen Storage Disease Type II Infantile Onset
    • Gainesville, Florida
      University of Florida Clinical Research Center
    Jan 18, 2023

    Lysosomal Storage Diseases, Metachromatic Leukodystrophy Trial in Milan (OTL-200)

    Recruiting
    • Lysosomal Storage Diseases
    • Metachromatic Leukodystrophy
    • OTL-200
    • Milan, Italy
      Ospedale San Raffaele - Telethon Institute for Gene Therapy (OSR
    Nov 16, 2022

    Lysosomal Storage Disease, Metachromatic Leukodystrophy Trial in Milan (OTL-200 Gene Therapy)

    Active, not recruiting
    • Lysosomal Storage Disease
    • Metachromatic Leukodystrophy
    • OTL-200 Gene Therapy
    • Milan, Italy
      Ospedale San Raffaele - Telethon Institute for Gene Therapy (OSR
    Nov 4, 2022

    Adeno-Associated Virus Antibody Study in Subjects OTC

    Recruiting
    • Ornithine Transcarbamylase Deficiency
    • +2 more
      • Akron, Ohio
      • +2 more
      Jul 22, 2022

      Lipid Storage Disease Trial in Istanbul

      Not yet recruiting
      • Lipid Storage Disease
        • Istanbul, Turkey
          Istanbul University
        Mar 29, 2022

        Glycogen Storage Disease Type IA Trial in Worldwide (genetic, other, drug)

        Recruiting
        • Glycogen Storage Disease Type IA
        • DTX401
        • +3 more
        • Orange, California
        • +16 more
        Jan 13, 2023

        Vitamin D and Adipose Tissue: a Complex Relationship

        Completed
        • Hypovitaminosis D
          • Verona, Italy
            Azienda Ospedaliera Universitaria Integrata
          Jul 14, 2023

          Opioid Misuse Trial (Text Message, Pamphlet)

          Not yet recruiting
          • Opioid Misuse
          • Text Message
          • (no location specified)
          Aug 15, 2022

          Glycogen Storage Disease Type IA Trial in Groningen ([6,6-2H2]glucose)

          Completed
          • Glycogen Storage Disease Type IA
          • [6,6-2H2]glucose
          • Groningen, Netherlands
            University of Groningen, UMC Groningen
          Feb 10, 2022

          Glycogen Storage Disease Trial in United States (mRNA-3745)

          Recruiting
          • Glycogen Storage Disease
          • Farmington, Connecticut
          • +4 more
          Jun 10, 2022

          Natural History of Pompe Disease

          Recruiting
          • Glycogen Storage Disease Type II, Adult
            • Garches, Hauts-de-Seine, France
              Hôpital Raymond Poincaré
            Apr 20, 2022

            GSD1 Trial in Worldwide (DTX401)

            Completed
            Has Results
            • GSD1
            • DTX401
            • steroid regimen
            • Farmington, Connecticut
            • +5 more
            Oct 25, 2022

            Glycogen Storage Disease Type III Trial in Worldwide (biological, other, drug)

            Recruiting
            • Glycogen Storage Disease Type III
            • UX053
            • +4 more
            • Orange, California
            • +9 more
            Jul 22, 2022

            Glycogen Storage Disease Type I Trial in Durham (Triheptanoin)

            Completed
            • Glycogen Storage Disease Type I
            • Durham, North Carolina
              Duke University Medical Center
            Dec 14, 2021

            MPS I, MPS II, MPS IVA Trial in San Francisco (Aldurazyme (laronidase))

            Recruiting
            • MPS I
            • +8 more
            • Aldurazyme (laronidase)
            • San Francisco, California
              University of California
            Apr 21, 2022

            Platelet Storage Lesion(PSL)in Platelet Concentrates

            Not yet recruiting
            • Platelet Storage Lesion(PSL)
              • (no location specified)
              Dec 2, 2021

              Enhancing Operability inHypobaric Hypoxic Environment WithSmall

              Not yet recruiting
              • Hypobaric Hypoxemia
                • (no location specified)
                Feb 14, 2022

                An In Vivo 24-Hour Recovery Study of Leukoreduced RBCs After

                Completed
                • Device Validation of In-vivo Performance
                • Reveos® Automated Blood Processing System
                • Cincinnati, Ohio
                • +1 more
                Jul 5, 2022

                Glycogen Storage Disease Type II Trial in Worldwide (Alglucosidase alfa GZ419829)

                Recruiting
                • Glycogen Storage Disease Type II
                • Alglucosidase alfa GZ419829
                • Leuven, Belgium
                • +8 more
                Jan 17, 2023

                A Storage Facility for Tissues Obtained From Malignant Melanoma

                Recruiting
                • Melanoma
                • Biospecimen Collection
                • Columbus, Ohio
                  Ohio State University Comprehensive Cancer Center
                Nov 6, 2022

                Pompe Disease (Late-onset) Trial (No Intervention)

                Not yet recruiting
                • Pompe Disease (Late-onset)
                • No Intervention
                • (no location specified)
                Nov 21, 2023